| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.012 | 0.9 |